Year archive

MESOBLAST LTD — 2017 filings

All 123 regulatory filings released by MESOBLAST LTD (MESO) in 2017, sourced directly from the official regulator.

123 Filings

2017 Period

2017 filings (123)

Filing	Released	Lang
6-K Regulatory Filings	2017-12-22	English
Change of Director's Interest Notice 2 pages 95.3KB Director's Dealing	2017-12-21	English
6-K Regulatory Filings	2017-12-21	English
Mesoblast Receives RMAT For LVAD Heart Failure Patients 3 pages 93.7KB Regulatory Filings	2017-12-20	English
Mesoblast's P3 GVHD Trial Completes Enrollment 2 pages 98.6KB Regulatory Filings	2017-12-19	English
Release of shares from voluntary escrow 1 page 88.0 Regulatory Filings	2017-12-19	English
6-K Regulatory Filings	2017-12-18	English
Mesoblast Grants TiGenix License For Treatment of Fistulae 3 pages 80.7KB Capital/Financing Update	2017-12-14	English
6-K Regulatory Filings	2017-12-11	English
MSB Named Global Technology Leader In Cell Therapy Industry 2 pages 95.7KB Regulatory Filings	2017-12-07	English
Change in substantial holding 5 pages 267.9KB Major Shareholding Notification	2017-12-06	English
Change in substantial holding 5 pages 275.5KB Major Shareholding Notification	2017-12-04	English
Response to ASX Aware Letter Query 7 pages 522.5KB Regulatory Filings	2017-11-16	English
6-K Regulatory Filings	2017-11-16	English
6-K Regulatory Filings	2017-11-16	English
6-K Interim / Quarterly Report	2017-11-16	English
Chairman's Address to Shareholders 2 pages 98.8KB AGM Information	2017-11-15	English
CEO Presentation to 2017 Annual General Meeting 43 pages 3.9MB AGM Information	2017-11-15	English
Results of Meeting 2 pages 172.4KB Declaration of Voting Results & Voting Rights Announcements	2017-11-15	English
First Quarter Results On Form 6K 71 pages 385.4KB Interim / Quarterly Report Q1 2018	2017-11-14	English
First Quarter Results Presentation 45 pages 3.9MB Investor Presentation	2017-11-14	English
Mesoblast Provides Corporate Update and Q1 Financial Results 8 pages 207.0KB Interim / Quarterly Report Q1 2018	2017-11-14	English
Ceasing to be a substantial holder 14 pages 2.7MB Major Shareholding Notification	2017-11-14	English
RA Phase 2 Trial Results Presented At ACR Annual Meeting 5 pages 140.4KB Regulatory Filings	2017-11-12	English
Becoming a substantial holder 52 pages 6.6MB Major Shareholding Notification	2017-11-12	English
Mesoblast Presents At Credit Suisse Healthcare Conference 2 pages 76.7KB Investor Presentation	2017-11-08	English
6-K Regulatory Filings	2017-11-01	English
Appendix 4C - quarterly 6 pages 117.7KB Interim / Quarterly Report Q1 2018	2017-10-30	English
Ceasing to be a substantial holder 28 pages 1.1MB Major Shareholding Notification	2017-10-29	English
Becoming a substantial holder 53 pages 4.2MB Major Shareholding Notification	2017-10-26	English
Ceasing to be a substantial holder 2 pages 121.9KB Major Shareholding Notification	2017-10-26	English
6-K Regulatory Filings	2017-10-18	English
S-8 Regulatory Filings	2017-10-17	English
Appendix 4G and Corporate Governance Statement 20 pages 182.3KB Governance Information	2017-10-15	English
Notice of Annual General Meeting/Proxy Form 14 pages 300.3KB AGM Information	2017-10-15	English
Annual Report to shareholders 214 pages 3.0MB Annual Report FY 2017	2017-10-15	English
6-K Regulatory Filings	2017-10-10	English
Appendix 3B 6 pages 81.6KB Share Issue/Capital Change	2017-10-05	English
6-K Regulatory Filings	2017-10-02	English
6-K Director's Dealing	2017-09-28	English
End-Stage Heart Failure Trial Completes Enrollment 3 pages 126.2KB Regulatory Filings	2017-09-27	English
Change of Director's Interest Notices 10 pages 238.3KB Director's Dealing	2017-09-24	English
Mesoblast Corporate Updates at Healthcare Conferences 2 pages 96.4KB Investor Presentation	2017-09-24	English
6-K Capital/Financing Update	2017-09-19	English
Appendix 3B 9 pages 142.6KB Capital/Financing Update	2017-09-17	English
Mesoblast Completes A$50.7 Million Raise 2 pages 92.2KB Capital/Financing Update	2017-09-14	English
6-K Director's Dealing	2017-09-07	English
Change in substantial holding 5 pages 86.4KB Major Shareholding Notification	2017-09-05	English
Change of Director Interest and Substantial Holding Notices 5 pages 335.3KB Director's Dealing	2017-09-05	English
6-K Regulatory Filings	2017-09-01	English
Retail Entitlement Offer 26 pages 702.5KB Capital/Financing Update	2017-08-31	English
20-F 30 JUNE 2017 Annual Report FY 2017	2017-08-30	English
6-K Regulatory Filings	2017-08-30	English
Preliminary Final Report including Appendix 4E 217 pages 1.5MB Annual Report FY 2017	2017-08-29	English
Annual Financial Results Presentation 33 pages 3.4MB Annual Report FY 2017	2017-08-29	English
Mesoblast Reports on Annual and Fourth Quarter Results 12 pages 268.2KB Interim / Quarterly Report FY 2017	2017-08-29	English
Underwritten A$50.7M Raise Closes Institutional Allocation 2 pages 94.9KB Capital/Financing Update	2017-08-28	English
Trading Halt 2 pages 342.2KB Capital/Financing Update	2017-08-24	English
Fully Underwritten A$50.7 Million Entitlement Offer 4 pages 182.1KB Capital/Financing Update	2017-08-24	English
Fully Underwritten Entitlement Offer Presentation 58 pages 3.9MB Capital/Financing Update	2017-08-24	English
Appendix 3B 9 pages 144.7KB Capital/Financing Update	2017-08-24	English
Cleansing notice 1 page 148.0KB Capital/Financing Update	2017-08-24	English
Potential For Accelerated Market Entry In Advanced CHF 3 pages 100.2KB Capital/Financing Update	2017-08-22	English
6-K Regulatory Filings	2017-08-18	English
Positive Results of MSB Therapy in Osteoarthritis Published 3 pages 121.3KB Regulatory Filings	2017-08-15	English
Release of shares from voluntary escrow 1 page 88.1 Share Issue/Capital Change	2017-08-07	English
6-K Regulatory Filings	2017-08-03	English
Appendix 4C - quarterly 6 pages 100.3KB Interim / Quarterly Report Q4 2017	2017-07-30	English
Regulatory Filings 2017 Regulatory Filings	2017-07-24	English
Capital/Financing Update 2017 Capital/Financing Update	2017-07-20	English
Regulatory Filings 2017 Regulatory Filings	2017-07-19	English
6-K Capital/Financing Update	2017-07-17	English
Change in substantial holding 5 pages 266.6KB Major Shareholding Notification	2017-07-12	English
FORM F-3 Capital/Financing Update	2017-07-10	English
Cleansing notice and Appendix 3B 10 pages 240.5KB Share Issue/Capital Change	2017-07-09	English
6-K Regulatory Filings	2017-06-27	English
Mesoblast RA Results Presented At EULAR Congress 2 pages 78.2KB Regulatory Filings	2017-06-21	English
MESO-Q3FY17-31MAR2017 Interim / Quarterly Report	2017-05-25	English
Third Quarter Financial Results On Form 6-K 125 pages 4.1MB Interim / Quarterly Report 9M 2017	2017-05-24	English
Third Quarter Results Presentation 34 pages 3.1MB Investor Presentation	2017-05-24	English
MSB Provides Q3 Operational Highlights and Financial Results 9 pages 246.4KB Interim / Quarterly Report 9M 2017	2017-05-24	English
6-K Director's Dealing	2017-05-05	English
6-K Regulatory Filings	2017-05-03	English
Change of Director's Interest Notice 3 pages 94.5KB Director's Dealing	2017-05-01	English
Appendix 4C - quarterly 6 pages 101.5KB Interim / Quarterly Report Q3 2017	2017-04-27	English
Change in substantial holding 10 pages 405.7KB Major Shareholding Notification	2017-04-23	English
6-K Regulatory Filings	2017-04-13	English
Successful Interim Analysis in Phase 3 Heart Failure Trial 3 pages 374.8KB Capital/Financing Update	2017-04-09	English
6-K Regulatory Filings	2017-04-07	English
Mesoblast Receives A$3.7m From Aus Govt For R&D 1 p Capital/Financing Update	2017-04-05	English
FDA Clears Heart Disease Trial At Boston Childrens Hospital 2 pages 99.0KB Regulatory Filings	2017-04-03	English
6-K Regulatory Filings	2017-04-03	English
Change in substantial holding 6 pages 285.7KB Major Shareholding Notification	2017-04-02	English
6-K Regulatory Filings	2017-03-31	English
Process Initiated For CHF P3 Interim Analysis 2 pages 97.7KB Regulatory Filings	2017-03-30	English
Cleansing notice and Appendix 3B 9 pages 240.7KB Share Issue/Capital Change	2017-03-30	English
Becoming a substantial holder from TEK 4 pages 111.8KB Major Shareholding Notification	2017-03-30	English
Mesoblast Raises US$40 Million 2 pages 95.8KB Capital/Financing Update	2017-03-26	English
6-K Regulatory Filings	2017-03-20	English
Durable Three Year Outcomes in Disc Disease 3 pages 110.4KB Regulatory Filings	2017-03-14	English
6-K Regulatory Filings	2017-03-08	English
FDA Grants Mesoblast Fast Track Designation For GVHD 2 pages 97.7KB Regulatory Filings	2017-03-06	English
MESO-Q2FY17-31DEC2016 Interim / Quarterly Report	2017-02-28	English
Half Year Report and Accounts (including Appendix 4D) 133 pages 4.1MB Interim / Quarterly Report H1 2017	2017-02-26	English
Half Year Results Presentation 35 pages 2.8MB Interim / Quarterly Report H1 2017	2017-02-26	English
Mesoblast Provides Half Year Results And Corporate Update 9 pages 226.3KB Interim / Quarterly Report H1 2017	2017-02-26	English
6-K Regulatory Filings	2017-02-17	English
Positive Nine Month RA Results For Mesoblast Cell Therapy 6 pages 190.8KB Regulatory Filings	2017-02-15	English
Presentation On Mesoblast RA P2 9 Month Trial Results 24 pages 2.6MB Investor Presentation	2017-02-15	English
SC 13G Major Shareholding Notification	2017-02-14	English
MESOBLAST LIMITED Major Shareholding Notification	2017-02-14	English
SC 13G/A Major Shareholding Notification	2017-02-13	English
Published Results Show MSB Cells Effective In RA Model 2 pages 122.1KB Regulatory Filings	2017-02-12	English
Release of shares from voluntary escrow 1 page 88.2 Share Issue/Capital Change	2017-02-09	English
6-K APPENDIX 4C Regulatory Filings	2017-02-03	English
Mesoblast Director Recognized For Cardiovascular Leadership 2 pages 96.4KB Regulatory Filings	2017-01-30	English
Appendix 4C - quarterly 6 pages 63.6KB Interim / Quarterly Report Q2 2016	2017-01-30	English
6-K JPM PRESENTATION Regulatory Filings	2017-01-17	English
MSB Presentation To Annual J.P.Morgan Healthcare Conference 38 pages 3.9MB Investor Presentation	2017-01-12	English
6-K - JP MORGAN PRESENTATION Regulatory Filings	2017-01-12	English
6-K MALLINCKRODT SHARE ISSUE Regulatory Filings	2017-01-12	English
Presentation at JP Morgan Healthcare Conference 1 p Investor Presentation	2017-01-10	English
MSB Receives A$29.6Million, Appendix 3B Share Issue 10 pages 244.4KB Capital/Financing Update	2017-01-08	English

Filings by year

2026 66 filings
2025 202 filings
2024 141 filings
2023 127 filings
2022 135 filings
2021 101 filings
2020 152 filings
2019 117 filings
2018 107 filings
2017 123 filings
2016 97 filings
2015 92 filings
2014 55 filings
2013 53 filings
2012 34 filings
2011 60 filings
2010 63 filings
2009 56 filings
2008 55 filings
2007 48 filings
2006 62 filings
2005 55 filings
2004 14 filings